Products for Research Use Only
RegisterLogin

SARS-CoV-2-IN-110

CAT: 0804-HY-170922Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-170922Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
SARS-CoV-2-IN-110 (compound Bb1) is a SARS-CoV-2 inhibitor. SARS-CoV-2-IN-110 exhibits antiviral efficacy against SARS-CoV-2 with an EC50 of 1.10 μM and significantly lower toxicity compared to Lapatinib. SARS-CoV-2-IN-110 inhibits SARS-CoV-2 with a CC50 of > 100 μM, with a selectivity index (SI) of >91[1].
UNSPSC
12352005
Target
SARS-CoV
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Smiles
ClC1=CC(NC2=NC=NC3=CC=CC=C32)=CC=C1OCC4=CC(C(NC5=CC=CC=C5F)=O)=CC=C4
Molecular Formula
C28H20ClFN4O2
Molecular Weight
498.94
References & Citations
[1]Adediji A, et al. Design, synthesis, and antiviral activity of fragmented-lapatinib aminoquinazoline analogs towards SARS-CoV-2 inhibition. Eur J Med Chem. 2025 Mar 15;286:117303.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-135856-01SARS-CoV-IN-2
HY-175460SARS-CoV-2-IN-117
HY-174320SARS-CoV-2-IN-112
HY-170767SARS-CoV-2-IN-109
HY-156337SARS-CoV-2-IN-63
HY-143417SARS-CoV-2-IN-16
HY-162777SARS-CoV-2-IN-93
HY-162414SARS-CoV-2-IN-84
HY-148387SARS-CoV-2-IN-35
HY-168107SARS-CoV-2-IN-98

Alternative Products

CatalogName
GTR19249570-01SARS-CoV-2-IN-110
GTR18678023-01SARS-CoV/SARS-CoV-2 Spike Antibody
BA1949-5SARS-CoV-IN-2
553226SARS-CoV-2
Oneq-S827-150RSARS CoV-2
MBS561139-01anti-Coronavirus (SARS-CoV-2) COVID Antibody-Monoclonal (Clone# 110)
MCV19-80A-110Anti-Coronavirus (SARS-CoV-2) COVID Antibody - Monoclonal (Clone #110)
C21524-50uLSARS-CoV/SARS-CoV-2 Nucleocapsid Antibody [E8H21]
GTR18595045-01SARS CoV/SARS CoV 2 Spike Human mAb

Popular Products